E N D
1. Surrogate Markers of Pro-Arrhythmic Risk Peter Kowey, MD, FACC
Mainline Heart Health Center
2. CP-2 QT Risk Assessment Comprehensive preclinical assessment
3. CP-3 Myocardial Wedge Preparation QT interval
Transmural dispersion of repolarization (TDR)
Early afterdepolarizations (EADs)
4. CP-4 Specific Drugs in the Myocardial Wedge Preparation
5. CP-5 QT Risk Assessment Comprehensive preclinical assessment
Careful measurement of the QT effect in appropriate studies
6. CP-6 QT Risk Assessment Comprehensive preclinical assessment
Careful measurement of the QT effect in appropriate studies
Observation for relevant events in clinical trials